Lev Gerlovin is speaking during the summit on “Adopting New Strategies to Support Cell & Gene Therapy Development.”
For more information on this event, click here.
France’s temporary authorisation (ATU) programme: reform implications
The temporary authorisation for use (Autorisation Temporaire d’Utilisation, ATU) programme in France is intended to provide early access to medicines for...